Stockscreener 앱 받기
35.54
5.15%
1.74
시간 외 거래:
35.54
전일 마감가:
$33.80
열려 있는:
$34.01
하루 거래량:
1.94M
Relative Volume:
0.70
시가총액:
$5.39B
수익:
$3.24B
순이익/손실:
$304.90M
주가수익비율:
17.09
EPS:
2.08
순현금흐름:
$156.70M
1주 성능:
+6.03%
1개월 성능:
-8.40%
6개월 성능:
-30.07%
1년 성능:
-44.21%
1일 변동 폭
$34.01
$35.86
1주일 범위
$33.06
$35.86
52주 변동 폭
$30.00
$72.94
Bruker Corp Stock (BRKR) Company Profile
명칭
Bruker Corp
전화
978663-3660
주소
40 MANNING RD, BILLERICA, MA
BRKR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
35.54 | 5.19B | 3.24B | 304.90M | 156.70M | 2.08 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-12-19 | 개시 | Guggenheim | Buy |
| 2024-12-10 | 개시 | UBS | Neutral |
| 2024-12-05 | 업그레이드 | Goldman | Sell → Neutral |
| 2024-10-15 | 개시 | Barclays | Overweight |
| 2024-09-30 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-02-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2022-10-21 | 개시 | UBS | Buy |
| 2022-08-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-10-15 | 재개 | Cowen | Market Perform |
| 2021-06-15 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2021-02-05 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | 개시 | Goldman | Sell |
| 2020-11-16 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | 다운그레이드 | Cleveland Research | Buy → Neutral |
| 2020-04-02 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | 다운그레이드 | Needham | Strong Buy → Hold |
| 2020-03-26 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-11-15 | 개시 | Stifel | Hold |
| 2019-09-26 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | 업그레이드 | Goldman | Sell → Neutral |
| 2019-06-24 | 재확인 | Needham | Strong Buy |
| 2019-06-21 | 재확인 | BofA/Merrill | Neutral |
| 2019-05-30 | 개시 | Wolfe Research | Peer Perform |
| 2019-05-06 | 재확인 | Needham | Strong Buy |
| 2019-05-03 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | 업그레이드 | UBS | Sell → Neutral |
| 2019-04-12 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2019-02-12 | 재확인 | BTIG Research | Buy |
| 2019-01-03 | 개시 | Needham | Strong Buy |
모두보기
Bruker Corp 주식(BRKR)의 최신 뉴스
Bruker acquires Austria based biocrates - MSN
Bruker plans to file for a stay of NanoString GeoMX injunction ruling - MSN
Comparing Bruker Corporation in custom built stock radarsJuly 2025 Pullbacks & Stepwise Trade Signal Implementation - Newser
Published on: 2025-08-15 21:28:58 - Newser
Technical signs of recovery in Bruker CorporationGlobal Markets & Real-Time Stock Entry Alerts - Newser
What’s the recovery path for long term holders of Bruker CorporationEarnings Overview Summary & Momentum Based Trading Signals - Newser
Leading vs lagging indicators on Bruker Corporation performanceWeekly Trade Analysis & Proven Capital Preservation Tips - Newser
Bruker's Strategic Reengineering: Navigating ACA/GOV Headwinds to Unlock Margin Expansion - AInvest
Scion Asset Management Discloses Q2 Holdings: New Buys, Reduced Stake in Estee Lauder. - AInvest
Candlestick Signal Suggests Reversal in Bruker CorporationWeekly Stock Report & Short-Term Trading Alerts - newsimpact.co.kr
Clover Health, Surgery Partners, Illumina, Bruker, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know - ca.finance.yahoo.com
US Bancorp DE Buys 480 Shares of Bruker Corporation (NASDAQ:BRKR) - Defense World
5 Must-Read Analyst Questions From Bruker’s Q2 Earnings Call - Yahoo Finance
Is Bruker Corporation stock risky to hold nowJuly 2025 PostEarnings & Comprehensive Market Scan Insights - thegnnews.com
10X Genomics Q2 Earnings Call Highlights: Balancing Growth and Challenges with Strong China Performance and Favorable Bruker Settlement - AInvest
Bruker Corp To Go Ex-Dividend On September 23rd, 2025 With 0.05 USD Dividend Per Share - 富途牛牛
Bruker Announces Quarterly Cash Dividend of $0.05 per Share. - AInvest
Bruker, Viatris, Sotera Health Company, Align Technology, and Omnicell Stocks Trade Up, What You Need To Know - Yahoo Finance
Bruker Maintains Quarterly Dividend of $0.05 per Share, Payable Oct. 3 to Holders of Record as of Sept. 23 - MarketScreener
Bruker to pay $0.05 quarterly dividend in October By Investing.com - Investing.com Canada
Bruker to pay $0.05 quarterly dividend in October - Investing.com
Bruker Announces Quarterly Dividend - Stock Titan
PNC Financial Services Group Inc. Has $728,000 Stock Position in Bruker Corporation (NASDAQ:BRKR) - Defense World
Bruker's Q2 Earnings Miss Estimates, Stock Tumbles, Margins Contract - Nasdaq
Bruker Secures Multi-Year Contracts for Explosives and Chemical Trace Detection in Aviation and Defense Sectors - The Globe and Mail
Why Investors Shouldn't Be Surprised By Bruker Corporation's (NASDAQ:BRKR) 31% Share Price Plunge - simplywall.st
Bruker Corporation (BRKR): A Bull Case Theory - MSN
` - Insider Monkey
Bruker Corp. (BRKR) Faces Funding Challenges, But Long-Term Fundamentals Remain Intact. - AInvest
Bruker Corp. (BRKR) Sheds 8.6% on Dismal Earnings, Outlook - MSN
Investors Don't See Light At End Of Bruker Corporation's (NASDAQ:BRKR) Tunnel And Push Stock Down 26% - 富途牛牛
Wells Fargo Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $50 - 富途牛牛
Unlocking Bruker (BRKR) International Revenues: Trends, Surprises, and Prospects - Yahoo Finance
Bruker Corporation shares rise 1.11% premarket after securing multi-year contracts for explosives and chemical trace detection solutions. - AInvest
Bruker Corporation Earnings Miss: Revenue Growth Expected to Slow Down in 2025 - AInvest
Earnings Miss: Bruker Corporation Missed EPS By 38% And Analysts Are Revising Their Forecasts - Yahoo Finance
Bruker Bets On Science, But Debt And Margins Weigh Heavy - Finimize
Beyond the Balance Sheet: What SWOT Reveals About Bruker Corp (B - GuruFocus
Bruker Corporation (NASDAQ:BRKR) Q2 2025 Earnings Call Transcript - Insider Monkey
Bruker Secures Contracts for Explosives, Chemical Trace Detection - MarketScreener
Bruker Corp secures multi-year contracts for trace detection - MarketScreener
BRUKER CORP SEC 10-Q Report - TradingView
Bruker's Strategic Cost-Saving Initiatives and Margin Expansion Justify Buy Rating Amid Market Challenges - AInvest
These Analysts Slash Their Forecasts On Bruker After Weaker-Than-Expected Q2 ResultsBruker (NASDAQ:BRKR) - Benzinga
Bruker stock price target lowered to $40 by TD Cowen on weak demand - Investing.com
J.P. Morgan Maintains Bruker Corp(BRKR.US) With Buy Rating, Announces Target Price $50 - 富途牛牛
A Quick Look at Today's Ratings for Bruker Corp(BRKR.US), With a Forecast Between $38 to $60 - 富途牛牛
Stifel lowers Bruker stock price target to $40 on weak academic spending - Investing.com Canada
JPMorgan lowers Bruker stock price target to $50 from $60, maintains Overweight rating - Investing.com
JPMorgan lowers Bruker stock price target to $50 from $60, maintains Overweight rating By Investing.com - Investing.com South Africa
Bruker Stock: Caution Warranted Despite Bullish Analyst Calls - 富途牛牛
Bruker Corp (BRKR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Bruker Corp 주식 (BRKR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| ORNELL JOHN A | Director |
May 13 '25 |
Option Exercise |
18.15 |
5,000 |
90,750 |
31,445 |
| LINTON WILLIAM A | Director |
Apr 22 '25 |
Option Exercise |
24.00 |
10,000 |
240,000 |
58,723 |
| Bures Thomas | Chief Accounting Officer |
Mar 10 '25 |
Buy |
47.40 |
500 |
23,698 |
3,472 |
| LAUKIEN FRANK H | PRESIDENT & CEO |
Feb 18 '25 |
Buy |
50.92 |
20,000 |
1,018,330 |
38,459,563 |
| PACKER RICHARD A | Director |
Dec 02 '24 |
Option Exercise |
19.12 |
10,000 |
191,200 |
84,254 |
| PACKER RICHARD A | Director |
Dec 02 '24 |
Sale |
57.82 |
3,350 |
193,683 |
80,904 |
0.89%
자본화:
|
볼륨(24시간):